我国基本药物制度现状、问题与展望

Challenges and Prospects of Essential Medicine System in China

2009年以来,国家卫生行政管理部门通过颁布系列法规制度,遴选并调整了多版基本药物目录,初步建立了我国基本药物制度,为提升药品供应保障能力发挥了重要作用。随着医疗卫生体制改革的不断深入,人民群众用药需求也发生了较大变化,药品供应保障体系相关政策相继颁布实施,我国基本药物制度也面临新的问题与挑战。本文回顾了2009年以来我国基本药物制度建立与实施的基本情况,通过分析基本药物制度当前面临的形势与问题,对未来该制度的优化与调整提出建议。

Since 2009,the state health administrative departments have issued a series of laws and regulations,selected and adjusted multiple editions of the essential medicine list,and preliminarily established essential medicine systems,which has played a significant role in improving the drug supply in China.Along with the healthcare reform,the needs of the general public for medicines have also changed drastically.Other related policies for the drug supply system have been successively promulgated and implemented,but the system for essential medicines is facing many problems and challenges.The establishment and implementation of essential medicine systems since the start of healthcare reform in 2009 were reviewed,the status quo and problems were analyzed,and corresponding countermeasures for the optimization and adjustment of the system were put forward in this paper.